XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income $ 19,013 $ 822
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 40,194 37,614
Amortization of deferred financing costs 1,370 521
Credit loss expense 88 32
Deferred income tax benefit (2,836) (921)
Equity-based employee and director compensation expense 954 754
Loss on dispositions and lease terminations, net 302 51
Changes in operating assets and liabilities, net of acquisitions (4,426) 2,141
Net cash provided by operating activities 54,659 41,014
Cash flows from investing activities:    
Principal payments received on notes receivable 66 85
Proceeds from sale of assets 3,793 5,600
Capital expenditures (16,403) (21,911)
Cash paid in connection with acquisitions, net of cash acquired (1,885) (4,166)
Net cash used in investing activities (14,429) (20,392)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 57,600 57,000
Repayments on revolving credit facilities (61,620) (36,399)
Borrowings under the Term Loan Facility 1,120  
Repayments on the Term Loan Facility (24,600)  
Net proceeds from issuance of preferred membership interests 24,430  
Payments of finance lease obligations (1,337) (1,287)
Payments of deferred financing costs (6)  
Distributions paid on distribution equivalent rights (93) (63)
Distributions paid on common units (39,800) (39,765)
Net cash provided used in financing activities (44,306) (20,514)
Net increase in cash and cash equivalents (4,076) 108
Cash and cash equivalents at beginning of period 7,648 513
Cash and cash equivalents at end of period $ 3,572 $ 621